The observation study on clinical effectiveness of NBP on patients with non-disabling ischemic cerebrovascular disease

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-16008069

Enrollment

Unknown

Registered

2016-03-08

Start date

2016-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-disabling ischemic cerebrovascular disease

Interventions

Two cohorts:Used or not used butyl phthalide

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. aged >= 18, gender not limited; 2. Onset the stroke or TIA no more than 48 hours; 3. non-disabling acute ischemic stroke patients (admitted to hospital NIHSS=4); 4. Obtained the signed the informed consent from patients or patients with legally authorized representatives.

Exclusion criteria

Exclusion criteria: 1. according to the baseline head CT or MRI diagnosis of bleeding or other pathological brain disorders, such as vascular malformation, tumor, abscess or other common non ischemic cerebral diseases (such as multiple sclerosis); 2. iatrogenic stroke; 3. thrombolysis therapy (veins or arteries) patients; 4. before the onset mRS score > 2 points; 5. with serious heart, liver, kidney and other viscera disfunctional; 6. serious mental disorders and dementia patients; 7. during pregnancy, lactation and planned pregnancy patients.

Design outcomes

Primary

Measure	Time frame
The incidence of stroke;	—

Countries

China

Contacts

Public ContactXu Anding

The first affiliated hospital of JiNan university

tlil@jnu.edu.cn+86 13392692160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026